AI is transforming clinical development, but what happens when usage costs spike? Jon Newton explains how to govern it before the bill lands.
- Two Planning Mistakes That Quietly Sink Clinical Programs
- Duplicate Tech, Not Technology, Is Burning Out Trial Sites
- The Real Reason Clinical Trial Systems Don't Talk To Each Other
- The Vendor Questions Most Clinical Tech Buyers Forget To Ask
- AI In Clinical Trials: Stop Hyping It, Start Proving It
- What AI Can't Fix In Decentralized Clinical Trial Data
- Decentralized Trials Promised Less Burden. Did They Deliver?
- Wireless Connectivity Is A Data Integrity Issue, Not IT
ON-DEMAND WEBINARS
Drug development in neurology is notoriously challenging. Despite being one of the most active areas of clinical development, neurological disease drug trials have among the longest development timelines and highest failure rates in the industry. In this webinar, learn how digital clinical measures enabled by wearables have great potential to transform and accelerate drug development in neuroscience.
Explore how AI‑powered search, intelligent data capture, and ontology‑driven structure streamline scientific discovery and documentation, as well as how structured data unlocks smarter analysis.
In this webinar, explore the importance of eCOAs, how they have evolved from the standard paper diaries, and what efficiencies you can realize from them.
Chief Scientific Officer Christine Guo, Ph.D., provides key insights into DHTs aimed at empowering study teams to strategically integrate these technologies into their clinical development initiatives.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![clinical-sites-GettyImages-2057440780]( "Why Are Clinical Trial Sites Are Absorbing Increased Complexity?")
Why Are Clinical Trial Sites Are Absorbing Increased Complexity?Site coordinators are overwhelmed by disconnected systems. Learn how unified trial technology can ease that load and free up time for patients.
-
![GettyImages-2117176337-diversity]( "Analyzing The FDA's Approach To Diversity In Clinical Trials")
Analyzing The FDA's Approach To Diversity In Clinical TrialsLearn how utilizing diverse data resources and collaborating with stakeholders enables sponsors to foster a culture of inclusivity, meet regulatory requirements and ultimately advance medical science.
-
![GettyImages-1307583047 Friends on Phones]( "Bringing Clinical Research To The Patient Using Patient-Centric Tech")
Bringing Clinical Research To The Patient Using Patient-Centric TechBy fostering daily interactions between patients and technology, these smart hubs offer a sustainable approach to ensuring the success and integrity of clinical trials in an evolving landscape of drug development.
-
![GettyImages-1344606074 data insights]( "Data-Driven Adaptive Trials Enhance Safety, Progress, And Economics")
Data-Driven Adaptive Trials Enhance Safety, Progress, And EconomicsBy offering guidance on optimizing ROI from extensive data collections and various endpoints in clinical studies, learn how IRT technology can enhance the data-driven approach for sponsors.
-
![Depression-gettyimages-1309050890]( "Improving Patient Outcomes With Wearables In Major Depressive Disorder")
Improving Patient Outcomes With Wearables In Major Depressive DisorderLearn how medical-grade wearable devices can help advance treatments in conditions like major depressive disorder and paint a more complete picture of patients with this often debilitating condition.
-
![doctors laptop iStock-1196710776]( "Reduce Time, Cost, & Risk With Clinical Study Data Review Software")
Reduce Time, Cost, & Risk With Clinical Study Data Review SoftwareSee how a top 10 global biopharmaceutical company implemented a single data review system to reduce the time, cost, and risk of running its clinical trials while accelerating the time to market.
-
![Healthcare-app-GettyImages-1142528978]( "Unified Patient Apps: The Future Of Trial Simplicity")
Unified Patient Apps: The Future Of Trial SimplicityA unified patient app streamlines clinical trial participation by combining scheduling, questionnaires, travel, and payments—reducing burden, improving engagement, and supporting better retention and data quality.
-
![GettyImages-1869998960 patient, doctor, clincial trial]( "Phase 4 Trials: A Critical Component Of Post-Marketing Insight")
Phase 4 Trials: A Critical Component Of Post-Marketing InsightUncover how Phase 4 trials play an essential role in gathering additional real-world data on the treatment’s performance over a longer period of time and in more diverse patient populations.
-
![GettyImages-1398569507 regulatory]( "5 Ways To Get Ready For IRT Regulatory Inspections")
5 Ways To Get Ready For IRT Regulatory InspectionsPreparing for a regulatory inspection during a clinical trial can be daunting. Learn about the importance of clear roles, audit trails, data integrity, and training, and get recommendations to help.
-
![GettyImages-1307583047 Friends on Phones]( "Why Native Apps Trump Web Apps For Security And Performance")
Why Native Apps Trump Web Apps For Security And PerformanceExplore the advantages of native applications in clinical research, including better performance, user experience, security, and integration capabilities.
- The Data Was Already There: RWE's Real Bottleneck Is People
- Two Planning Mistakes That Quietly Sink Clinical Programs
- Duplicate Tech, Not Technology, Is Burning Out Trial Sites
- The Real Reason Clinical Trial Systems Don't Talk To Each Other
- The Vendor Questions Most Clinical Tech Buyers Forget To Ask
RECENT NEWSLETTERS
- 09.05.26 -- Best Of August: AI, FDA RWE, And Trial Data Risks
- 09.03.26 -- AI, APIs, and eConsent Are Exposing Trial Workflow Gaps
- 08.27.26 -- Patient Data Breaks Down When Trial Systems Miss Reality
- 08.20.26 -- Clinical AI Validation, Trial Handoffs, And Smarter Study Builds
- 08.13.26 -- AI Urgency, Site-Sponsor Gaps, And Data That Saves Lives
